Data from Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan Patients

Abstract

<div>Abstract<p>Women of African descent have the highest breast cancer mortality in the United States and are more likely than women from other population groups to develop an aggressive disease. It remains uncertain to what extent breast cancer in Africa is reminiscent of breast cancer in African American or European American patients. Here, we performed whole-exome sequencing of genomic DNA from 191 breast tumor and non-cancerous adjacent tissue pairs obtained from 97 African American, 69 European American, 2 Asian American, and 23 Kenyan patients. Our analysis of the sequencing data revealed an elevated tumor mutational burden in both Kenyan and African American patients, when compared with European American patients. <i>TP53</i> mutations were most prevalent, particularly in African American patients, followed by <i>PIK3CA</i> mutations, which showed similar frequencies in European American, African American, and the Kenyan patients. Mutations targeting <i>TBX3</i> were confined to European Americans and those targeting the <i>FBXW7</i> tumor suppressor to African American patients whereas mutations in the <i>ARID1A</i> gene that are known to confer resistance to endocrine therapy were distinctively enriched among Kenyan patients. A Kyoto Encyclopedia of Genes and Genomes pathway analysis could link <i>FBXW7</i> mutations to an increased mitochondrial oxidative phosphorylation capacity in tumors carrying these mutations. Finally, Catalogue of Somatic Mutations in Cancer (COSMIC) mutational signatures in tumors correlated with the occurrence of driver mutations, immune cell profiles, and neighborhood deprivation with associations ranging from being mostly modest to occasionally robust. To conclude, we found mutational profiles that were different between these patient groups. The differences concentrated among genes with low mutation frequencies in breast cancer.</p>Significance:<p>The study describes differences in tumor mutational profiles between African American, European American, and Kenyan breast cancer patients. It also investigates how these profiles may relate to the tumor immune environment and the neighborhood environment in which the patients had residence. Finally, it describes an overrepresentation of <i>ARID1A</i> gene mutations in breast tumors of the Kenyan patients.</p></div>